Q32 Bio Inc. SEC filings QTTB
Q32 Bio Inc. has 588 filings in SEC EDGAR's recent list, going back to Jan 6, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Jul 28, 2026 | — |
| S-3 | Shelf registration | Jul 17, 2026 | — |
| 424B5 | Prospectus supplement | Jul 15, 2026 | — |
| 424B5 | Prospectus supplement | Jul 13, 2026 | — |
| S-3 | Shelf registration | Jun 25, 2026 | — |
| 424B5 | Prospectus supplement | Apr 24, 2026 | — |
| 424B5 | Prospectus supplement | Mar 27, 2026 | — |
| S-8 | Employee stock plan registration | Mar 10, 2026 | — |
| 424B5 | Prospectus supplement | Feb 17, 2026 | — |
| POS AM | Filing | Apr 11, 2025 | — |
| S-3 | Shelf registration | Apr 11, 2025 | — |
| S-8 | Employee stock plan registration | Mar 11, 2025 | — |
| 424B3 | Prospectus | Mar 11, 2025 | — |
| 424B3 | Prospectus | Mar 10, 2025 | — |
| 424B3 | Prospectus | Feb 10, 2025 | — |
| 424B3 | Prospectus | Dec 11, 2024 | — |
| 424B3 | Prospectus | Nov 7, 2024 | — |
| 424B3 | Prospectus | Aug 8, 2024 | — |
| 424B3 | Prospectus | Jul 9, 2024 | — |
| S-8 | Employee stock plan registration | May 31, 2024 | — |
| 424B3 | Prospectus | May 9, 2024 | — |
| 424B3 | Prospectus | Apr 29, 2024 | — |
| S-1 | Registration statement | Apr 19, 2024 | — |
| 424B3 | Prospectus | Mar 13, 2024 | — |
| 424B3 | Prospectus | Feb 14, 2024 | — |
| S-4/A | Filing | Feb 13, 2024 | — |
| S-4/A | Filing | Feb 12, 2024 | — |
| S-4/A | Filing | Jan 29, 2024 | — |
| S-4 | Registration for a merger or exchange | Dec 18, 2023 | — |
| S-3 | Shelf registration | Mar 9, 2023 | — |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| 424B5 | Prospectus supplement | Apr 8, 2021 | — |
| 424B5 | Prospectus supplement | Apr 7, 2021 | — |
| POS AM | Filing | Mar 11, 2021 | — |
| S-3ASR | Automatic shelf registration | Mar 12, 2020 | — |
| 424B5 | Prospectus supplement | Apr 10, 2019 | — |
| 424B5 | Prospectus supplement | Apr 8, 2019 | — |
| S-3 | Shelf registration | Apr 1, 2019 | — |
| S-8 | Employee stock plan registration | Mar 29, 2018 | — |
| 424B4 | Prospectus | Mar 29, 2018 | — |
| FWP | Free writing prospectus | Mar 27, 2018 | — |
| S-1/A | Amended registration statement | Mar 27, 2018 | — |
| S-1/A | Amended registration statement | Mar 23, 2018 | — |
| S-1/A | Amended registration statement | Mar 19, 2018 | — |
| S-1 | Registration statement | Mar 2, 2018 | — |
Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QTTB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1661998
- Former names
- Q32 Bio Inc. (until Nov 4, 2026); Homology Medicines, Inc. (until Mar 22, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.